Seeking Alpha
Profile| Send Message|
( followers)  

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday July 30.

Bullish Calls:

  • Regeneron (NASDAQ:REGN), Celgene (NASDAQ:CELG), Biogen Idec (NASDAQ:BIIB), Gilead (NASDAQ:GILD), Seattle Genetics (NASDAQ:SGEN), Isis Pharmaceuticals (NASDAQ:ISIS): "In biotech, I like Regeneron, Celgene, Biogen Idec and Gilead. I also like Seattle Genetics and Isis Pharmaceuticals."
  • EMC (NYSE:EMC): "Long term, it might be okay. Now, I'm not crazy about it, but because of saber rattling, it is going higher."
  • Pitney Bowes (NYSE:PBI): "It has moved so much, but those guys are smart, they are doing a lot of great things. It can go higher."
  • Thermo Fisher Scientific (NYSE:TMO): "That was a good quarter, and you did well in that. I urge you to stay with this."
  • DexCom (NASDAQ:DXCM), Edwards Lifesciences (NYSE:EW), St. Jude Medical (NYSE:STJ): "We had DexCom on. I like that company. I think someone might want to buy it. I like Edwards Lifesciences and St. Jude. DexCom is a great spec, but Edwards is best in show."
  • Priceline (NASDAQ:PCLN): "We don't care about the split. Splits have helped some stocks, but you want this one for the earnings."

Bearish Calls:

  • GT Advanced Technologies (GTAT): "This stock is going the wrong way."
  • Arena Pharmaceuticals (NASDAQ:ARNA): "I'm not a fan of it. People got mad at me because of that, but the stock is down."
  • Seadrill (NYSE:SDRL): "This is really a conundrum, because I believe the yield is safe, but there is weakness in the platform business. You may pick up the yield, but you are not going to get upside in the stock."


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.

Source: Cramer's Lightning Round - 6 Biotech Picks (7/30/14)